T7 Therapeutics

T7 Therapeutics is a biotechnology company focused on developing a new generation of mRNA therapeutics and vaccines by engineering the T7 RNA polymerase. The company's core technology involves optimizing the enzymatic properties of T7 RNA polymerase to improve the yield, purity, and stability of synthetic mRNA. By addressing the limitations of current mRNA production methods, T7 Therapeutics aims to enable more effective and scalable treatments across oncology, infectious diseases, and rare genetic disorders. The company operates primarily in the pre-clinical stage, leveraging its proprietary protein engineering platform to create high-performance mRNA manufacturing solutions.